Literature DB >> 30122514

A recurrent de novo DYNC1H1 tail domain mutation causes spinal muscular atrophy with lower extremity predominance, learning difficulties and mild brain abnormality.

Sophelia Hoi Shan Chan1, Nens van Alfen2, Inger Johanne Thuestad3, Janice Ip4, Angel On-Kei Chan5, Christopher Mak6, Brian Hon-Yin Chung6, Aad Verrips7, Erik-Jan Kamsteeg8.   

Abstract

We describe four unrelated patients with the same de novo heterozygous missense mutation c.751C>T in the DYNC1H1 gene. We found a high phenotype-genotype correlation with all four patients having early childhood-onset predominant lower limb muscle weakness and wasting which was slowly progressing and later-onset mild upper extremities proximal weakness. All four patients presented minor cognitive dysfunction with learning difficulty and developmental behavioural comorbidities with mild abnormalities in the brain MRI. The leg muscle MRI findings are highly consistent in DYN1CH1-related spinal muscular atrophy with lower limb predominance (SMALED) with relative sparing of biceps femoris and semitendinosus, and hypertrophy of adductor longus in the thighs; and sparing the anterior and medial muscles in the calves. This report provides important clinical evidence indicating the de novo heterozygous missense mutation c.751C>T in the DYNC1H1 gene is pathogenic causing SMALED. Muscle MRI is more specific than muscle biopsy in the diagnosis of SMALED.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain MRI; Dynein cytoplasmic 1 heavy chain 1 (DYNC1H1) gene; Muscle MRI; Spinal muscular atrophy with lower extremity predominance (SMALED)

Mesh:

Substances:

Year:  2018        PMID: 30122514     DOI: 10.1016/j.nmd.2018.07.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  The regulatory function of the AAA4 ATPase domain of cytoplasmic dynein.

Authors:  Xinglei Liu; Lu Rao; Arne Gennerich
Journal:  Nat Commun       Date:  2020-11-23       Impact factor: 14.919

2.  Integrated transcriptomic and metabolomic analysis of rat serum to investigate potential target of puerarin in the treatment post-traumatic stress disorder.

Authors:  Aishan Su; Xiaoyun Chen; Zijing Zhang; Bo Xu; Chaoqun Wang; Zhongyuan Xu
Journal:  Ann Transl Med       Date:  2021-12

3.  The clinical-phenotype continuum in DYNC1H1-related disorders-genomic profiling and proposal for a novel classification.

Authors:  Lena-Luise Becker; Hormos Salimi Dafsari; Jens Schallner; Dalia Abdin; Michael Seifert; Florence Petit; Thomas Smol; Levinus Bok; Lance Rodan; Ingrid Krapels; Stephanie Spranger; Bernhard Weschke; Katherine Johnson; Volker Straub; Angela M Kaindl; Nataliya Di Donato; Maja von der Hagen; Sebahattin Cirak
Journal:  J Hum Genet       Date:  2020-08-12       Impact factor: 3.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.